Comparative Diagnostic Performance of ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in the Evaluation of Recurrent Prostate Cancer
Year: 2023
Type: article
Study design: Observational Study
Abstract: This investigation compares how effectively 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI identify prostate cancer (PCa) recurrence following initial therapy and examines how the results of these two tracers relate to clinical and pathological variables. Thirty-five men experiencing biochemical relapse (BCR) underwent restaging with 68Ga-PSMA PET/MRI, and 31 of them also completed a 68Ga-DOTA-RM2 PET/MRI examination within a period of up to 16 days (mean interval: 3 days; range: 2–16 days). Imaging obtain
DOI: 10.51847/ibu5dgs8wp
Institutions: Nanjing Drum Tower Hospital, Nanjing University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4416937193
